Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Liver abscess
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
Three types of abscess, differentiated by causative organism: * Pyogenic * Amoebic * Fungal == '''Pyogenic abscesses''' == * '''Risk factors''' ** Diabetes ** Underlying hepatobiliary disease (cirrhosis) ** CKD ** History of malignancy ** Liver transplant *** Specifically risks are: **** Hepatic infarction from vascular thrombosis or anastomotic stenosis **** Ischaemic cholangiopathy **** Biliary anastomotic stricture *** Treatment is similar to non-transplant setting * '''Aetiology''' ** Cryptogenic process (43%) *** ?undiagnosed abdominal disease, resolved infectious process, host factors making infection more likely *** ERCP is only indicated in patients with some sort of finding suggesting a malignancy *** Need a thorough workup for cause ** Biliary ductal system (ascending cholangitis) - 38% - mostly underlying malignancy, in non-transplant setting *** Risks - biliary-enteric anastomosis, Caroli disease, biliary ascariasis, any biliary tract surgery ** Seeded through portal blood flow (5%) *** Diverticulitis, appendicitis, pancreatitis, IBD, PID, perforated viscus, omphalitis, CRC ** Haematogenous spread - hepatic artery (3%) *** Endocarditis, pneumonia, osteomyelitis *** More common in immunosuppressed patients ** Injury from trauma or liver-directed therapy (2%) ** Direct extension from adjacent disease (1%) *** Cholecystitis, subphrenic abscess, perinephric abscess, perforation of bowel directly into liver * '''Pathophysiology''' ** Abscess occurs when an inoculum of bacteria exceeds the liver's ability to clear it, resulting in tissue invasion, neutrophil infiltration, and formation of an organised abscess ** Sources described above *** Biliary - usually occurs as biliary obstruction causing stasis, colonisation, infection, and ascension (ascending suppurative cholangitis). Mostly intra-hepatic stones in Asia and malignancy in Western countries. *** Ascending PV infection - has become much less frequent after antibiotics *** Systemic - micro-abscess formation is quite common at autopsy in patients dying of sepsis *** Trauma - intra-hepatic haematoma or necrosis can become an abscess, can present several weeks post-injury ** 75% of cases involve the right hemi-liver (unknown reason), caudate 5%, left hemi-liver 20%. Bilobar involvement is uncommon. ** Typically 1mm-4cm ** Most commonly gram-negative aerobes, and anaerobes *** Abscesses from pyelophlebitis or cholangitis are usually poly-microbial, while systemic infections are usually mono-microbial *** Sterile in 10-20% ** * '''Presentation''' ** Classic presentation is fever, jaundice and RUQ pain (seen in only 10%) ** Malaise, anorexia, nausea ** Jaundice is often due to underlying biliary disease ** Diaphragmatic symptoms - cough, dyspnoea ** ALP mildly elevated in 80%, bilirubin elevated in 20-50%, transaminases mildly elevated in 60% ** Endogenous endophthalmitis - specific to Klebsiella, most common in diabetics * '''Complications''' ** Rupture - peritonitis * '''Imaging''' ** CXR *** Elevated right hemidiaphragm *** Right pleural effusion *** RLL atelectasis *** Abnormal extraluminal gas in RUQ *** PV gas if pylephlebitis is source (GIT -> PV) ** USS *** Sensitivity 80-95% *** Not as good for lesions high up in the dome of the liver ** CT *** Sensitivity 95-100% *** Gas, rim enhancement ** ** MRI/MRCP *** Equally sensitive to CT * '''Differential diagnosis''' ** Sub-phrenic or other intra-peritoneal abscess ** Amoebic abscess *** Sometimes not possible to differentiate - need to aspirate or trial anti-amoebic antibiotics ** Echinococcal cyst/hydatid disease (differentiate on imaging) ** * '''Management''' ** Principles *** Treat abscess and its primary source *** Test for amoebic serology if indicated *** Abx and drainage ** Medical *** BCs then Abx *** Base Abx on presumed source **** Colonic - cef/met **** Biliary - taz **** Consider meropenem if recurrent cholangitis **** Liver transplant - cover fungi **** Skin or endocarditis - vanc for MRSA *** Extended duration Abx - up to 6/52, but duration is not well-defined ** Drainage (almost always required) *** Percutaneous (successful in 66-90% of cases) **** Send pus for culture, including mycobacterium and fungi if immunosuppressed **** Success rate seems to be higher with drainage catheter rather than one-off aspiration (100% vs 60%) **** Contraindications: multiple large abscesses >5cm (however generally still worth trying), intra-abdominal source requiring surgery, ascites, requirement for transpleural drainage, coagulopathy, proximity to vital structures. *** Surgical **** Indications: percutaneous contra-indicated, failed non-op therapy, surgery required for something else, abscesses >5cm **** Remember to send histo looking for entamoeba and cancer **** Very rarely, partial hepatectomy is required ***** Infected hepatic malignant neoplasm ***** Hepatolithiasis ***** Intra-hepatic biliary stricture ***** Severe destruction from infection * '''Prognosis''' ** Mortality now <10% == '''Amoebic liver abscess (extraintestinal manifestation of Entamoeba histolytica infection)''' == '''Epidemiology''' * 55% of those in endemic areas are infected, but <50% of those are symptomatic * Mexico, India, Africa, parts of central and south America '''Risk factors''' * Most common in adult men (20-40), despite more even gender balance for colonic amoebic disease * Migrants from India, Africa, Mexico, Central/South America ** Generally uncommon in short-term travellers * HIV or other immunosuppression '''Pathophysiology''' * Entamoeba histolytica infection - protozoan, existing as a trophozoite or cyst * All other species in the genus Entamoeba are non-pathogenic, and not all strains of histolytica are virulent * Faecal-oral transmission - ingestion of mature cyst, excystation occurs in small bowel which releases trophozoites which migrate to large bowel. These produce cysts, which are passed in faeces. * Asymptomatic carriers - cysts confined to intestinal lumen * Symptomatic - cysts invade through intestinal mucosa * Liver is most common extraintestinal manifestation ** Also brain and lungs * Liver abscesses occur in 1% of patients with amoebiasis (ascends via portal system) * Mostly causes a single focus in right lobe ** Liquefactive necrosis ** Fluid described as 'anchovy sauce' and is odourless unless secondary bacterial infection has occurred ** Progressive hepatic necrosis continues until the Glisson capsule is reached, which is resistant to hydrolysis by the amoebae; therefore the cavity tends to abut the liver capsule when found ** Chronic abscesses can develop a fibrous capsule and even calcify * Patients rapidly develop anti-amoebic antibodies, but this does not appear to halt progression of disease '''Presentation''' * Between months to several years after return from endemic area * Usually 1-2 weeks RUQ pain, high fever. ** Cough, sweating, malaise, weight loss, anorexia, hiccough * Hepatomegaly, point tenderness over liver * Be aware of rupture risk - peritonitis, but can also extend into chest * Can also cause hepatic vein/IVC thrombosis * Leukocytosis without eosinophilia * Elevated ALP +/- other LFTs, hyperbilirubinaemia is unusual * 10-20% have diarrhoea * '''Diagnosis''' * Definitive diagnosis is with identification of E. histolytica trophozoites in pus or serum antibodies * Aspiration is diagnostic only 10-20% of the time * Abnormalities will be seen on USS or CT or MRI ** CXR - abnormal in 50% - elevated hemidiaphragm, atelectasis, pleural effusion ** USS - round, well-defined hypoechoic mass ** CT - low-density mass with peripheral enhancing rim ** MRI - low T1, high T2 ** Will be seen as 'cold' on a liver radionucleotide scan as opposed to a 'hot' pyogenic abscess ** Can take up to 2 years for complete radiologic resolution ** Most commonly posterior right lobe, mostly solitary subcapsular lesions ** If in left lobe, concern for pericardial extension * Commonly also see raised right hemidiaphragm on CXR * Confirm with serological or antigenic testing - can take 7 days to become positive but 99% sensitivity after that ** Currently difficult to differentiate between active acute infection and past infection * Maybe stool microscopy * '''Differential diagnosis''' * See pyogenic abscess section for differentiating features * Echinococcal disease - differentiate based on imaging/serology * Malignancy - usually no symptoms from mass '''Management''' * Principles ** Drainage is only necessary if: *** No clinical response after 5-7 days of Abx *** Abscess at high risk for rupture (5cm in diameter, or in the left liver) *** Deterioration - diagnosis confirmation needed ** Drainage is actually rarely required ** If no response to medication, could have bacterial coinfection - usually responds in 3 days * Don't commonly see trophozoites in aspirate but you can do other antigen/PCR testing * Treat with tissue agent (to eliminate liver organisms) + luminal agent (to eliminate intraluminal cysts, even if not seen in the stool) ** Tissue agent - metronidazole 400mg PO TDS Β 7-10 days *** Tinidazole also an option ** Luminal - eg paramomycin 25-30 mg/kg per day, in 3 divided doses, for 7 days ** If no improvement, consider aspiration/drainage or extended course * Peritoneal rupture (size of abscess is most important risk factor) ** Percutaneous drainage of collections ** Laparotomy if doubtful diagnosis, hollow viscus perforation, fistulisation resulting in haemorrhage or sepsis, failure of conservative therapy * Pleural rupture ** Thoracentesis * Look for other extraintestinal manifestations ** Pleuropulmonary infection ** Cardiac infection ** Brain abscess ** Cutaneous infection '''Follow-up''' * Should do follow-up imaging to ensure resolution * May take up to 9 months to resolve == '''Fungal abscesses''' == * Risk factors ** Almost always immunosuppressed patients, typically from chemotherapy ** Solid organ or bone marrow transplant ** Indwelling stents/drains * Causative agents ** Typically Candida (80%) ** Aspergillus ** Cryptococcus * Treatment ** Antimicrobials *** Step down to oral fluconazole *** Beware of combined fungal/bacterial abscesses ** Drainage *** Aspiration *** Drainage *** Surgical drainage [[Category:Liver]]
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Liver abscess
Add topic